Improving Sexually Transmitted Infection Screening and Treatment among People with or at Risk for HIV

Disclaimer: Per a court order, HHS is required to restore this website as of 11:59 PM February 14, 2025. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from the immutable biological reality that there are two sexes, male and female. The Trump Administration rejects gender ideology and condemns the harms it causes to children, by promoting their chemical and surgical mutilation, and to women, by depriving them of their dignity, safety, well-being, and opportunities. This page does not reflect biological reality and therefore the Administration and this Department rejects it.
 

Background

Sexually transmitted infections (STIs) are known to increase the risk of HIV transmission and acquisition with risky sexual behaviors. Although the national incidence of HIV infection has decreased over recent years, the rates of common STIs such as chlamydia (CT), gonorrhea (GC), and syphilis have not. In addition to increasing the risk of HIV transmission from a non-virally suppressed person, STIs are a continuing public health concern because of other associated morbidities and mortalities. Despite national recommendations for screening and treating STIs in people with HIV or at risk for HIV, gaps exist in the regular screening, treatment, and prevention of STIs among people with HIV.

Approach

This SPNS Initiative implemented needs-based training, clinical and non-clinical interventions. The goal was to improve screening, testing, and treatment of common bacterial STIs among people with HIV or at risk for HIV who are served by HRSA’s Ryan White HIV/AIDS Program (RWHAP) and/or Bureau of Primary Health Care (BPHC) funded clinics or health centers. Nine clinical demonstration sites in three United States (U.S.) jurisdictions, Florida, Louisiana, and Washington, D.C., were selected to participate in this pilot demonstration project because of higher than national average incidences of GC, CT, syphilis, and HIV.

A baseline needs assessment was conducted with each of the nine clinical demonstration sites. The goal was to inform the selection and subsequent evaluation of clinically appropriate interventions to increase and/or improve STI screening and treatment among people with HIV and people at risk for HIV.

Based on findings from the needs assessment the nine clinical demonstration sites implemented the following interventions:

InterventionIntervention type
Provider TrainingTraining
Self-Collected Nucleic Acid Amplification Test (NAAT) SpecimensClinical
Audio Computer-Assisted Self-Interview (ACASI) Sexual HistoryNon-Clinical
LGBTQ Welcoming SpaceNon-Clinical
Provider Detailing ProgramSystems Level

Effective interventions identified through this project include STI screening, testing, and treatment resources for national use to assist in dissemination of successful interventions for long-term sustainability across the United States.

Contact Information

Project Contacts:

John A. Nelson, PhD, CNS, CPNP
Principal Investigator
FXB Center, Rutgers University
Phone
973-972-6268

HRSA Contacts:

PO Name
Marlene Matosky, MPH, RN
PO Title
Project Officer
PO Phone
301-443-0798

Funding:

Funding Mechanism
Cooperative Agreement

Recipient Organization: François-Xavier Bagnoud (FXB) Center, Rutgers University

Grant number: U90HA32147

Project Period: 9/30/2018-9/29/2022